News

Filter

Current filters:

Cardio-vascularNexium

1 to 9 of 95865 results

Russia’s Peptogen launches production of innovative CV drugs

Russia’s Peptogen launches production of innovative CV drugs

20-08-2014

Sergei Sobyanin, Mayor of Moscow, has officially launched a new Russian plant for the production of innovative…

Cardio-vascularHeart attacksMoscowPeptogenPharmaceuticalProductionRussiaSergey SobyaninStrogino

Australia’s NHMRC reports on progress to improve clinical trials

Australia’s NHMRC reports on progress to improve clinical trials

20-08-2014

The National Health and Medical Research Council (NHMRC), tasked with implementing a range of initiatives…

AustraliaClinical researchNational Health and Medical Research CouncilPharmaceuticalRegulationResearchTrials portal

Clinigen adds to oncology portfolio with AstraZeneca’s Ethyol

Clinigen adds to oncology portfolio with AstraZeneca’s Ethyol

20-08-2014

UK-based Clinigen Group has acquired the global rights to the oncology support therapy Ethyol (amifostine)…

ClinigenClinigen GroupEthyolLicensingOncologyPharmaceuticalTreatment for head and neck cancerUK

Hikma's profits boosted in first half by good injectables sales

Hikma's profits boosted in first half by good injectables sales

20-08-2014

Revenue for Jordanian drugmaker Hikma Pharmaceuticals in the first half of 2014 rose 16% following a…

FinancialGenericsHikma PharmaceuticalsJordan

Eisai submits marketing authorization to the EU for Fycompa in new seizure indication

Eisai submits marketing authorization to the EU for Fycompa in new seizure indication

20-08-2014

Japanese drug major Eisai has submitted a marketing authorization application to the European Commission…

BrainCNS DiseasesEisaiEpilepsyFycompaJapanPartial-onset seizuresPharmaceuticalPrimary generalized tonic-clonic seizuresRegulationSeizure types

Novartis signs agreement with TB Alliance for development of its tuberculosis compounds

Novartis signs agreement with TB Alliance for development of its tuberculosis compounds

20-08-2014

Swiss drug major Novartis has signed an exclusive global licensing agreement with the Global Alliance…

Antibiotics and Infectious diseasesNovartisPharmaceuticalResearchSwitzerlandTB AllianceTropical diseasesTuberculosis

Roche to partner with the Garvan Institute in genomics research

Roche to partner with the Garvan Institute in genomics research

20-08-2014

Swiss drug major Roche and the Garvan Institute of Medical Research are to collaborate in the development…

AustraliaBiotechnologyDNA sequencingGarvan InstituteGeneticsGenomics technologiesJohn MattickResearchRocheSwitzerland

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

NICE U-turn on Celgene’s Revlimid for myelodysplastic syndromes

20-08-2014

UK drugs watch dog the National Institute for Health and Care Excellence (NICE) has issued final draft…

BiotechnologyCelgene Corp.Myelodysplastic syndromesOncologyPricingRegulationRevlimidUK

1 to 9 of 95865 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top